Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Capital Raise

Every capital raise filing by a US-listed company that our alert engine sent, newest first.

4:00 PM ET 8-K
Capital Raise Jefferies Credit Partners BDC Inc.

Jefferies Credit Partners BDC Capital Raise of $6.61M

Jefferies Credit Partners BDC Inc. sold 462,715.212 unregistered shares of its Class I common stock to third-party investors. The shares were sold at a price of $14.29202 per share, representing the company's NAV as of September 30, 2026, for total consideration of approximately $6.61 million.

Value
$6.61M
3:45 PM ET 8-K
Capital Raise Narragansett Bancorp, Inc. NARA

Narragansett Bancorp Capital Raise of $91M

Narragansett Bancorp, Inc. completed its initial public offering and two-tier holding company reorganization for BayCoast Bank on November 2, 2026. The company sold 9,098,800 shares of common stock at the adjusted maximum of its offering range, with shares beginning trade on the Nasdaq Capital Market under the symbol 'NARA'.

Value
$91M
3:42 PM ET 8-K
Capital Raise Willow Tree Capital Corp

Willow Tree Capital Capital Raise of $1.1M

Willow Tree Capital Corporation sold approximately 67,131 shares of common stock in a private placement for an aggregate offering price of $1.1 million. The shares were sold at a price of $15.97 per share pursuant to subscription agreements with investors under Regulation D exemptions.

Value
$1.1M
2:56 PM ET 8-K
Capital Raise Principal Credit Real Estate Income Trust

Principal Credit Real Estate Income Trust Capital Raise of $650K

Principal Credit Real Estate Income Trust sold 31,925.51 common shares for approximately $650,000 in a continuous private offering. The sale included Class F-S and Class F-I common shares to third-party investors under a Regulation D exemption.

Value
$650K
12:48 PM ET 8-K
Capital Raise Cottonwood Communities, Inc.

Cottonwood Communities Capital Raise of $2.83M

Cottonwood Communities, Inc. issued and sold 284,186 shares of its Series A Convertible Preferred Stock in a private placement offering between October 27 and November 3, 2026. The company received aggregate proceeds of approximately $2.83 million at a purchase price of $10.00 per share. This sale is part of an ongoing private offering of up to $200 million in preferred stock to accredited investors.

Value
$2.83M
12:02 PM ET 8-K/A
Capital Raise Macquarie Infrastructure Fund, L.P.

Macquarie Infrastructure Fund Capital Raise of $950K

Macquarie Infrastructure Fund, L.P. sold unregistered Class I limited partnership units for aggregate consideration of approximately $0.95 million on October 1, 2026. The sale was part of a continuous private offering to accredited investors and qualified purchasers, with the broader MIF Program raising approximately $131.0 million during the same period.

Value
$950K
9:07 AM ET 8-K
Capital Raise Lyell Immunopharma, Inc. LYEL

Lyell Immunopharma Capital Raise of $80M

Lyell Immunopharma entered into a securities purchase agreement to raise $80.0 million through a private placement of 7,428,040 shares of common stock. The shares were sold to institutional accredited investors at a price of $10.77 per share, with the company agreeing to file a resale registration statement within 30 days of closing.

Value
$80M
Counterparty
institutional accredited investors
9:00 AM ET 8-K
Capital Raise HarbourVest Private Equity Secondaries Fund L.P.

HarbourVest Private Equity Secondaries Fund Capital Raise of $1.95M

HarbourVest Private Equity Secondaries Fund L.P. sold 159,793 Class I Units for aggregate consideration of approximately $1.9 million on October 1, 2026. The sale was part of a continuous private offering to accredited investors and qualified purchasers, with the unit price finalized at a Transactional NAV of $12.17 per unit.

Value
$1.95M
8:41 AM ET 8-K
Capital Raise reAlpha Tech Corp. AIRE

reAlpha Tech Capital Raise of $1.75M

reAlpha Tech Corp. announced the pricing of a $1.75 million best efforts public offering of 4,375,000 shares of common stock (including pre-funded warrants) at $0.40 per share. The company intends to use the net proceeds for working capital, general corporate purposes, and potential acquisitions or litigation settlements.

Value
$1.75M
5:01 PM ET 8-K
Capital Raise SPACCircle Acquisition Corp. SCQC

SPACCircle Acquisition Capital Raise of $103M

SPACCircle Acquisition Corp. consummated its initial public offering of 10,000,000 units at $10.00 per unit, generating $100 million in gross proceeds. Simultaneously, the company completed a private placement of 266,590 units to its sponsor, SPACCircle Sponsor LLC, for approximately $2.67 million. A total of $100.5 million was placed in a trust account to fund a future business combination.

Value
$103M
Counterparty
SPACCircle Sponsor LLC
5:00 PM ET 8-K
Capital Raise Acadia Realty Trust AKR

Acadia Realty Trust Capital Raise

Acadia Realty Trust filed a new automatic shelf registration statement and entered into an amendment to its existing at-the-market (ATM) equity offering program. The amendment reflects the new registration statement and adds Citizens JMP Securities, LLC as a sales agent and forward purchaser for the program, which has approximately $199.1 million in capacity remaining.

Counterparty
BofA Securities, Inc.
4:32 PM ET 8-K
Capital Raise H2O America HTO

H2O America Capital Raise of $374M

H2O America completed the issuance and sale of 7,475,000 equity units, including the full exercise of the underwriters' over-allotment option, at a stated amount of $50 per unit. Each unit consists of a stock purchase contract obligating the holder to buy common stock by November 2029 and a beneficial interest in 5.300% Remarketable Senior Notes due 2031. The offering raised approximately $373.75 million in gross proceeds to be used for general corporate purposes.

Value
$374M
Counterparty
Wells Fargo Securities, LLC
Term
3 years
4:16 PM ET 8-K
Capital Raise Liminatus Pharma, Inc. LIMN

Liminatus Pharma Capital Raise of $650K

Liminatus Pharma entered into a subscription agreement with a non-U.S. investor for a private placement of 260,001 shares of common stock. The company raised gross proceeds of approximately $0.65 million at a price of $2.50 per share. The proceeds are intended for working capital and general corporate purposes.

Value
$650K
4:01 PM ET 8-K
Capital Raise Reed's, Inc. REED

Reed's Capital Raise of $10M

Reed's, Inc. entered into a securities purchase agreement with its majority stockholder, D&D Source of Life Holding, Ltd., for a $10.0 million private placement of 17,421,602 shares of common stock. The proceeds will be used for working capital and to satisfy a $10.0 million equity contribution requirement under the company's senior secured loan agreement.

Value
$10M
Counterparty
D&D Source of Life Holding, Ltd.
12:41 PM ET 8-K
Capital Raise Fortress Net Lease REIT FNLR

Fortress Net Lease REIT Capital Raise of $93.9M

Fortress Net Lease REIT issued and sold 8,730,792 common shares across multiple classes for gross proceeds of approximately $93.9 million in an unregistered private placement. Additionally, the company declared monthly distributions for all share classes to shareholders of record as of October 30, 2026.

Value
$93.9M
11:59 AM ET 8-K
Capital Raise Macquarie Infrastructure Income Opportunities Fund

Macquarie Infrastructure Income Opportunities Fund Capital Raise of $17.6M

Macquarie Infrastructure Income Opportunities Fund sold 691,489.361 Class J common shares for $17.55 million in its October 2026 monthly closing. The shares were issued as part of a continuous private offering at a price of $25.38 per share, which was the Fund's NAV as of September 30, 2026.

Value
$17.6M
11:51 AM ET 8-K
Capital Raise Kairos Pharma, LTD. KAPA

Kairos Pharma Capital Raise

Kairos Pharma, Ltd. entered into a third amendment to its existing equity line of credit (ELOC) purchase agreement with Helena Global Investment Opportunities I Ltd. The amendment extends the company's option to use the ELOC for an additional year until December 31, 2028, and follows previous amendments that adjusted the purchase price to 97% of VWAP and shortened the pricing period.

Counterparty
Helena Global Investment Opportunities I Ltd.
Term
through Dec 2028
11:34 AM ET 8-K
Capital Raise Bread Financial Holdings, Inc. BFH

Bread Financial Holdings Capital Raise of $125M

Bread Financial Holdings issued and sold 5,000,000 depositary shares, each representing a 1/40th interest in its new 9.375% Series C Non-Cumulative Perpetual Preferred Stock. The company also granted underwriters a 30-day option to purchase up to an additional 750,000 depositary shares. The issuance includes restrictions on junior stock dividends and repurchases if preferred dividends are not paid.

Value
$125M
10:59 AM ET 8-K
Capital Raise Kennedy Lewis Capital Co

Kennedy Lewis Capital Capital Raise of $780M

Kennedy Lewis Capital Company reported that it has raised approximately $780.5 million in total consideration through its continuous public offering and private placement as of October 1, 2026. The company also disclosed a net asset value (NAV) per share of $19.68 for Class I and Class D shares and $19.65 for Class S shares as of September 30, 2026.

Value
$780M
8:45 AM ET 8-K
Capital Raise Aeon Biopharma, Inc. AEON

Aeon Biopharma Capital Raise of $6.2M

AEON Biopharma entered into a warrant amendment to reduce the exercise price of its outstanding two-year milestone warrants from $0.3221 to $0.20 per share. Certain holders have agreed to exercise their warrants at this reduced price, which is expected to generate approximately $6.2 million in gross proceeds for the company. The warrants were triggered for accelerated expiration following FDA feedback on the company's ABP-450 biosimilar pathway and will expire on November 16, 2026.

Value
$6.2M
8:36 AM ET 8-K
Capital Raise Peraso Inc. PRSO

Peraso Capital Raise of $4M

Peraso Inc. completed a $4.0 million private placement with Nant Capital, LLC, issuing 3,271,355 shares of common stock and pre-funded warrants. The company also entered into a registration rights agreement requiring it to file a resale registration statement for the shares and warrant shares by November 27, 2026.

Value
$4M
Counterparty
Nant Capital, LLC
4:49 PM ET 8-K
Capital Raise Aspen Neuroscience, Inc. ASPE

Aspen Neuroscience Capital Raise of $141M

Aspen Neuroscience, Inc. completed its initial public offering (IPO) of 9,375,000 shares of common stock at a price of $15.00 per share. The offering generated gross proceeds of approximately $140.6 million. In connection with the closing, the company's amended and restated certificate of incorporation and bylaws became effective.

Value
$141M
4:06 PM ET 8-K
Capital Raise ISQ Open Infrastructure Co LLC

ISQ Open Infrastructure Co Capital Raise of $29.5M

ISQ Open Infrastructure Company LLC issued and sold unregistered shares across multiple classes for total aggregate net consideration of approximately $29.5 million. The shares were sold to investors for cash and issued to independent directors for services rendered. The company also reported its monthly Transactional Net Asset Value (NAV) per share as of September 30, 2026.

Value
$29.5M
3:47 PM ET 8-K
Capital Raise Third Point Private Capital Partners

Third Point Private Capital Partners Capital Raise of $1.15M

Third Point Private Capital Partners sold 42,493 Class I common shares in an unregistered private placement for total consideration of $1.15 million. The offering was conducted in reliance on Section 4(a)(2) and Regulation D/S exemptions for accredited investors and non-U.S. persons. The fund also disclosed a Net Asset Value (NAV) per share of $27.06 as of September 30, 2026.

Value
$1.15M
3:40 PM ET 8-K
Capital Raise Benchmark 2026-V24 Mortgage Trust

Benchmark 2026-V24 Mortgage Trust Capital Raise of $759M

Benchmark 2026-V24 Mortgage Trust entered into agreements to sell $682.4 million of publicly offered certificates and $76.9 million of privately offered certificates. The transaction is structured as a commercial mortgage-backed securities (CMBS) offering with a closing date expected on or about November 13, 2026.

Value
$759M
Counterparty
Goldman Sachs & Co. LLC
2:01 PM ET 8-K
Capital Raise Cottonwood Communities, Inc.

Cottonwood Communities Capital Raise of $2.01M

Cottonwood Communities, Inc. issued and sold 201,123 shares of its Series 2025 Preferred Stock in a private placement offering between October 19 and November 1, 2026. The company received aggregate proceeds of approximately $2.01 million from the sale, which is part of a larger $150 million private offering launched in December 2024.

Value
$2.01M
1:03 PM ET 8-K
Capital Raise Macquarie Infrastructure Fund, L.P.

Macquarie Infrastructure Fund Capital Raise of $950K

Macquarie Infrastructure Fund, L.P. sold unregistered Class I limited partnership units for $0.95 million as part of its continuous private offering. The broader MIF Program, which includes the Fund and other Macquarie-managed vehicles, has raised approximately $1,191.7 million in aggregate cash consideration since October 2025.

Value
$950K
7:01 AM ET 8-K
Capital Raise Vertical Data Inc. VDTA

Vertical Data Capital Raise of $4.2M

Vertical Data Inc. announced it intends to issue shares of common stock in a private placement transaction for gross proceeds of approximately $4.2 million. The company also disclosed a non-binding term sheet for a GPU-as-a-Service arrangement with a cloud provider involving 16,000 NVIDIA GPUs with a potential contract value of $2.8 billion.

Value
$4.2M
6:11 AM ET 8-K
Capital Raise Bhav Acquisition Corp II BHAI

Bhav Acquisition Corp II Capital Raise of $100M

BHAV Acquisition Corp II (SPAC) consummated its initial public offering (IPO) of 10,000,000 units at $10.00 per unit, generating gross proceeds of $100 million. Each unit consists of one Class A ordinary share and one right to acquire one-fourth of a share upon completion of a business combination. The company granted underwriters a 45-day option to purchase up to an additional 1.5 million units to cover over-allotments.

Value
$100M
Counterparty
Maxim Group LLC
6:08 AM ET 8-K
Capital Raise Regen BioPharma Inc RGBP

Regen BioPharma Capital Raise

Regen Biopharma entered into a $10 million equity line of credit with Coventry Enterprises, allowing the company to sell shares of common stock at a 20% discount to market prices over a 36-month term. Additionally, the company issued a $125,000 10% unsecured promissory note to Coventry, using a portion of the proceeds to satisfy $71,557 in existing convertible debt.

Counterparty
Coventry Enterprises, LLC
Term
36 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.